• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (5)
    • Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
    • Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients.
    • Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.
    • Sex differences in renal mitochondrial function: a hormone-gous opportunity for research.
    • Tooth Wear
    • See All 5 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci Rep. 2017 02 13; 7:42157.

View in: PubMed

subject areas
  • Apoptosis
  • Biological Assay
  • Cannabinoid Receptor Agonists
  • Cannabinoid Receptor Antagonists
  • Carcinoma, Transitional Cell
  • Caspase 3
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Fibroblasts
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Proto-Oncogene Proteins c-akt
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • Signal Transduction
  • Sphingolipids
  • src-Family Kinases
  • Urinary Bladder Neoplasms
  • Wound Healing

authors with profiles
  • Yusuf A. Hannun